4576 - 4600 of 7939 Results
Title
Year
-
OPENTitle: A new biology of cell penetrating peptidesJournal Name: Peptide SciencePublisher: WileyVol: 113Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pep2.24154Best OA location URL: https://wlv.openrepository.com/bitstream/2436/623251/3/Howl_Jones_A_new_biology_of_cell_penetrating_peptides_revision_2020.pdfCitation Count: 7
- Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients2020OPENTitle: Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic PatientsJournal Name: JAMA OncologyPublisher: American Medical Association (AMA)Vol: 6Issue #: 5Start Page: 714End Page: 714Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaoncol.2020.0001Best OA location URL: https://jamanetwork.com/journals/jamaoncology/articlepdf/2761984/jamaoncology_fehlmann_2020_oi_200001.pdfCitation Count: 102
-
OPENTitle: Transcriptomic signatures of brain regional vulnerability to Parkinson’s diseaseJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-020-0804-9Best OA location URL: https://www.nature.com/articles/s42003-020-0804-9.pdfCitation Count: 69
- Cognitive load amplifies Parkinson’s tremor through excitatory network influences onto the thalamus2020OPENTitle: Cognitive load amplifies Parkinson’s tremor through excitatory network influences onto the thalamusJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 5Start Page: 1498End Page: 1511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa083Best OA location URL: https://academic.oup.com/brain/article-pdf/143/5/1498/33281930/awaa083.pdfCitation Count: 47
- Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease2020RESTRICTEDTitle: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 433Issue #:Start Page: 53End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046Citation Count: 23
- Contributions of individual and combined Glu-B1x and Glu-B1y high-molecular-weight glutenin subunits to semolina functionality and pasta quality2020OPENTitle: Contributions of individual and combined Glu-B1x and Glu-B1y high-molecular-weight glutenin subunits to semolina functionality and pasta qualityJournal Name: Journal of Cereal SciencePublisher: Elsevier BVVol: 93Issue #:Start Page: 102943End Page: 102943Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jcs.2020.102943Best OA location URL: https://doi.org/10.1016/j.jcs.2020.102943Citation Count: 5
- Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes2020RESTRICTEDTitle: Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 4Start Page: 319End Page: 331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1737017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174089Citation Count: 27
- ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer’s disease2020OPENTitle: ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer’s diseaseJournal Name: AgingPublisher: Impact Journals, LLCVol: 12Issue #: 5Start Page: 4124End Page: 4162Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.18632/aging.102840Best OA location URL: https://doi.org/10.18632/aging.102840Citation Count: 4
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration2020OPENTitle: Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degenerationJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 387End Page: 397Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-020-0762-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101073Citation Count: 545
-
RESTRICTEDTitle: Essential tremor-plus: a controversial new conceptJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 266End Page: 270Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30398-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686582Citation Count: 91
- Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling2020OPENTitle: Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic SignalingJournal Name: Molecular CellPublisher: Elsevier BVVol: 77Issue #: 5Start Page: 1124End Page: 1142.e10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2019.11.013Best OA location URL: http://www.cell.com/article/S1097276519308421/pdfCitation Count: 158
-
OPENTitle: Impaired Motor Recycling during Action Selection in Parkinson’s DiseaseJournal Name: eneuroPublisher: Society for NeuroscienceVol: 7Issue #: 2Start Page: ENEURO.0492End Page: 19.2020Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0492-19.2020Best OA location URL: https://www.eneuro.org/content/eneuro/7/2/ENEURO.0492-19.2020.full.pdfCitation Count: 0
-
OPENTitle: Investigating lymphocyte populations in patients with Parkinson’s diseaseJournal Name: Annals of Translational MedicinePublisher: AME Publishing CompanyVol: 8Issue #: 6Start Page: 276End Page: 276Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/atm.2020.02.29Best OA location URL: https://atm.amegroups.com/article/viewFile/37712/pdfCitation Count: 3
-
RESTRICTEDTitle: Mitochondria at the interface between neurodegeneration and neuroinflammationJournal Name: Seminars in Cell & Developmental BiologyPublisher: Elsevier BVVol: 99Issue #:Start Page: 163End Page: 171Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.semcdb.2019.05.028Citation Count: 73
- Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 871Issue #:Start Page: 172914End Page: 172914Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914Citation Count: 19
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia2020OPENTitle: Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementiaJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 379End Page: 386Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-020-0755-1Best OA location URL: https://discovery.ucl.ac.uk/10093347/3/Zetterberg_Janelidze.pdfCitation Count: 778
-
RESTRICTEDTitle: Social Impact of Connected Landmark Lighting: A Social Sensing ApproachJournal Name: IEEE Internet of Things MagazinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #: 1Start Page: 64End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/iotm.0001.1900088Citation Count: 1
-
OPENTitle: Three-Plane–assembled Deep Learning Segmentation of GliomasJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 2Issue #: 2Start Page: e190011End Page: e190011Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/ryai.2020190011Best OA location URL: https://pubs.rsna.org/doi/pdf/10.1148/ryai.2020190011Citation Count: 23
-
RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 46
- An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases2020RESTRICTEDTitle: An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative DiseasesJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 3Start Page: 576End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9030576Best OA location URL: https://www.mdpi.com/2073-4409/9/3/576/pdf?version=1585198756Citation Count: 25
- Outcome measurement in functional neurological disorder: a systematic review and recommendations2020RESTRICTEDTitle: Outcome measurement in functional neurological disorder: a systematic review and recommendationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 6Start Page: 638End Page: 649Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2019-322180Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/6/638.full.pdfCitation Count: 82
- Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort study2020RESTRICTEDTitle: Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort studyJournal Name: Journal of Affective DisordersPublisher: Elsevier BVVol: 268Issue #:Start Page: 118End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jad.2020.02.046Citation Count: 21
- Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates2020OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Best OA location URL: https://eprints.whiterose.ac.uk/159502/1/acschembio.9b01044.pdfCitation Count: 6
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide2020OPENTitle: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 343End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12921Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12921Citation Count: 210